MedTrace Logo

Metoclopramide in Upper Gastrointestinal Bleed

NCT05746377 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-07-11

No results posted yet for this study

Summary

The goal of this clinical trial is to test if metoclopramide can improve effectiveness of endoscopic intervention in upper gastrointestinal (GI) bleeds. The main questions the investigators hope to answer is

Does metoclopramide lessen the need for repeat endoscopy, interventional radiology intervention or surgery in cases of upper GI bleed?

Does metoclopramide improve visibility of the GI walls in cases of upper GI bleed?

Conditions

  • Upper GI Bleeding
  • Bleeds Gastric
  • Bleed Ulcer
  • Hemorrhage Gastric
  • Hemorrhage; Ulcer

Interventions

DRUG

Metoclopramide 10mg

IV Metoclopramide

DRUG

Saline

Placebo

Sponsors & Collaborators

  • Mercy Health System

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-20
Primary Completion
2024-02-29
Completion
2024-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05746377 on ClinicalTrials.gov